CLINICAL ROLE -
Digoxin Linked to High Risk of Sudden Death in AFib
Patients with atrial fibrillation (AFib) have an increased risk of death when they take digoxin, a risk that increases with dosage, a study found.
Read More
Synthetic Cholesterol Drug Disappoints in Trial
Researchers sought to change the volume of fatty deposits in a coronary artery that was at least 30% blocked.
New Ebola Vaccine: 100% Effective
The researchers vaccinated known contacts of people with newly diagnosed Ebola infection. Some were vaccinated immediately, some not for 21 days. In all, there were 2,151 people vaccinated.
FDA Awards Breakthrough Status to Post Traumatic Stress Drug
Drug candidate can treat individuals who have PTSD associated with their military service.
Sitagliptin Equivalent to Insulin in Hospitalized Diabetics
Sitagliptin (Januvia/Merck) helps manage diabetes patients admitted hospital for general medical problems or surgery.
Magnesium May Reduce Diabetes Rates
A diet with foods rich in magnesium may reduce rates of cardiovascular disease, type 2 diabetes, and all-cause mortality.
Celecoxib May Be Safer Than Other Arthritis Treatments
Cox-2 inhibitors carry risk for arthritis patients with heart disease.
Hepatitis B Drug Combination Approved
Tenofovir-alafenamide combination approved by the FDA for chronic hepatitis B infection.
New HIV Drug Combination Shows Superiority
Dolutegravir/abacavir shows a solid safety profile and a high barrier to resistance.
Access to Hepatitis C Drugs in Prison Still Lagging
Obstacles exist in making testing and treatment for hepatitis C routine practice in prison.
Coinfection with HIV-Hepatitis C Can Increase Cancer Risk
Coinfection with HIV plus a hepatitis B, C, or both, adds to the risk of non-Hodgkins lymphoma.
FDA Approves Preloaded Syringe for Wet AMD
Lucentis treats wet age-related macular degeneration and macular edema after retinal vein occlusion.
HIV PrEP Can Be Effective Post-Exposure
Many patients wait until after becoming infected with HIV to seek treatment.
MRI Improves Liver Cancer Screening
Ultrasound not deemed to be sufficiently sensitive to detect early stage liver cancer.
FDA Approves New Diabetes Combination Therapy
Canagliflozin and metformin hydrochloride extended release (Invokamet) improves blood glucose control in adults with type 2 diabetes.
Diabetes Combo Gets FDA Approval
Canagliflozin with extended release formulation of metformin improves blood glucose control in type 2 diabetes.
Hepatitis C-HIV Coinfection Under Medicaid Managed Care
Navigating prior authoization requirements for patients coinfected with hepatitis C and HIV remains a challenge.
Discontinuation of Infliximab May Cause Relapse of Ulcerative Colitis
Restarting infliximab after discontinuation can still be effective in ulcerative colitis, however.
Major Insurers to Cover Early Hepatitis C Treatment in New York
Decision will make direct-acting antivirals available to 40% of the state's estimated 60,000 Medicaid patients with chronic HCV.
Can Direct-Acting Antiviral Drugs Cure Hepatitis C in 6 Weeks?
A typcial treatment regimen for hepatitis C virus lasts 12 weeks at a high cost.
Experimental Drug May Lessen Hepatitis C Treatment Duration
Novel drug RG-101 could shorten the treatment time for hepatitis C virus (HCV) infection to 4 weeks.
New Antiviral Drug Shows Superior Results in Hepatitis C
Zepatier achieves sustained virologic response rate of 99.2% during a 12 to 16 week treatment course in patients with HCV.
FDA Eases Restrictions on Abortion Drug
Mifepristone is now approved for use up to 70 days after the first day of a woman's last menstrual period.
New Asthma Therapy Shows Promise
Adding tiotropium bromide inhalation spray to other asthma therapies improved lung function and symptom control.
Does Drug Abuse Prevent Effective Hepatitis C Treatment?
Research explores treatment of drug users with hepatitis C virus (HCV) infection with direct-acting antivirals.
Dietary Changes in Multiple Sclerosis
Most MS patients have not considered changing their diet as a therapeutic approach.
Opioid Drug Abuse Linked to Increase in Hepatitis C Rate
Most new cases of hepatitis C infection in New York City found in the baby boomer generation.
Living in Present Key in MS Patient Outcomes
Acceptance is a multiple sclerosis treatment goal because it is associated with better drug adherence.
Multiple Sclerosis Drug Shows Promise in Clinical Setting
Fingolimid is an oral treatment for relapsing-remitting multiple sclerosis.